WHITEHOUSE STATION, N.J. & PRINCETON, N.J.--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and GE Healthcare today announced a clinical study collaboration, license and supply agreement for use of [18F]Flutemetamol, an investigational positron emission tomography (PET) imaging agent, to support Merck's development of MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).
business unit
tags
5 December, 2012 --- San Antonio, TX --- GE Healthcare, the healthcare division of General Electric Company (NYSE: GE) is working to help physicians potentially improve patient care throughout the breast cancer journey through one of the most comprehensive portfolios of technologies in the industry available today. While at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS 2012), taking place in San Antonio from December 5-7, GE Healthcare will provide attendees with an overview of its innovative breast cancer solutions for healthcare practitioners.
business unit
tags
Innovative fifteen-year agreement ensures Humber River Regional Hospital is always at the leading edge of technology in many critical areas.
MISSISSAUGA, ON -- OCTOBER 15, 2012 --- Toronto's Humber River Regional Hospital (HRRH) and GE Healthcare are pleased to announce an innovative fifteen-year agreement that will implement the first Managed Equipment Services (MES) solution in North America. An MES agreement is a flexible and tailored technology and service agreement to provide long term, sustainable access to innovative medical equipment and services.
business unit
tags